2[2]Pearman MD,Mcneeley SG.A review of the microbiology,immunology and clinical implications of clhlamydia trachom-atis infection[J].Obstet Gynecol Surv,1992,147(7):448-461.
6Garcla-Castillo M, Morosini MI, G61vez M, et al. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates[ J]. ] Antimicrob Chemother,2008,62 (5) : 1027-1030.
7Simmons WL, Dybvig K. Mycoplasma biofilms ex vivo and in vi- vo[J]. FEMS Microbiol Lett,2009,295( 1 ) :77-81.
